Join us for the season premiere of EASL Studio Season 8 as we unpack key insights from the Steatotic Liver Disease (SLD) Summit. Explore the evolving consensus on patient trajectories, advancements in ALD and MetALD treatment pathways, and the latest endpoint discussions. The episode also highlights a holistic approach to diagnosing and managing comorbidities and revisits the standard of care in light of breakthroughs in MASH treatments.
Moderator: Aleksander Krag
Faculty: Cyrielle Caussy, Sven Francque and Brian Lee
This EASL Studio is supported by Madrigal.
EASL has received no input from Madrigal with regards to the content of this programme.
Related episodes:
- S7E3 – The changing face of Steatotic Liver Disease: Navigating new opportunities and emerging challenges
- EASL Studio at the Congress 2024: SLD nomenclature: Need for refinement?
- EASL Studio at the Congress 2024: MASLD anno 2024: A rapidly changing landscape
- EASL Studio from EASL Congress 2023 – Steatotic liver disease global consensus to change nomenclature